BioCentury
ARTICLE | Financial News

Advaxis raises $20M in follow-on

March 2, 2018 8:49 PM UTC

Cancer immunotherapy company Advaxis Inc. (NASDAQ:ADXS) raised $20 million on Feb. 22 through the sale of 10 million shares at $2 in a follow-on underwritten by Jefferies and Guggenheim Securities.

The price is a 20% discount to the Advaxis' closing price of $2.51 on Feb. 21, when the company proposed the offering after market hours...

BCIQ Company Profiles

Advaxis Inc.